Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centruroides elegans CeII9 (also known as Beta-mammal toxin CeII-9) is a potent neurotoxin isolated from the venom of the Mexican scorpion Centruroides elegans [1]. It belongs to the beta-class of scorpion toxins, which are characterized by their ability to modulate the gating mechanism of voltage-gated sodium channels (Nav) [2]. Specifically, CeII9 binds to neurotoxin receptor site 4 on the sodium channel, shifting the voltage-dependence of activation toward more hyperpolarized potentials and reducing the peak sodium current [1, 2]. This action causes the channels to open at more negative membrane potentials, leading to spontaneous and repetitive firing of action potentials in neurons and muscle fibers [3]. Clinically, this results in severe envenomation symptoms, including muscle spasms, respiratory distress, and cardiovascular instability [2]. While CeII9 is not a therapeutic target for treating human diseases, it is the primary target for neutralization by therapeutic antivenoms such as Alacramyn [2]. In pharmacological research, CeII9 is used as a high-affinity probe to investigate the structural biology of sodium channels and the molecular basis of channelopathies [1, 3].
Neutralization of the toxin by specific antibody fragments, preventing its binding to voltage-gated sodium channels [2].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-mammal toxin CeII-9 (CeII-9).